Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclopentanes | 12 | 2015 | 21 | 3.310 |
Why?
|
| Cyclization | 27 | 2016 | 48 | 2.570 |
Why?
|
| Palladium | 6 | 2017 | 27 | 2.250 |
Why?
|
| Ketones | 7 | 2015 | 17 | 1.810 |
Why?
|
| Stereoisomerism | 22 | 2017 | 167 | 1.680 |
Why?
|
| Fluorenes | 2 | 2022 | 26 | 1.660 |
Why?
|
| Alkadienes | 4 | 2013 | 6 | 1.380 |
Why?
|
| Indicators and Reagents | 5 | 2022 | 58 | 1.090 |
Why?
|
| Acids | 2 | 2016 | 18 | 1.090 |
Why?
|
| Catalysis | 13 | 2017 | 179 | 1.090 |
Why?
|
| Biological Products | 3 | 2022 | 71 | 1.080 |
Why?
|
| Benzofurans | 2 | 2016 | 21 | 1.070 |
Why?
|
| 4-Butyrolactone | 2 | 2015 | 11 | 1.040 |
Why?
|
| Cannabinoids | 7 | 2021 | 56 | 0.930 |
Why?
|
| Fluorine | 1 | 2022 | 16 | 0.860 |
Why?
|
| Chrysenes | 1 | 2022 | 5 | 0.830 |
Why?
|
| Ethers | 5 | 2013 | 20 | 0.720 |
Why?
|
| Molecular Structure | 12 | 2021 | 492 | 0.690 |
Why?
|
| Receptor, Cannabinoid, CB2 | 7 | 2021 | 32 | 0.690 |
Why?
|
| Azetidines | 3 | 2023 | 7 | 0.640 |
Why?
|
| Indoles | 2 | 2008 | 158 | 0.550 |
Why?
|
| Receptor, Cannabinoid, CB1 | 6 | 2021 | 40 | 0.550 |
Why?
|
| Amines | 3 | 2015 | 39 | 0.540 |
Why?
|
| Dioxolanes | 1 | 2015 | 2 | 0.520 |
Why?
|
| Oceans and Seas | 1 | 2015 | 15 | 0.520 |
Why?
|
| Prostaglandins | 1 | 2015 | 27 | 0.510 |
Why?
|
| Methanol | 1 | 2015 | 18 | 0.510 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 149 | 0.490 |
Why?
|
| Imines | 2 | 2013 | 10 | 0.480 |
Why?
|
| Oxidation-Reduction | 5 | 2022 | 431 | 0.470 |
Why?
|
| Alkenes | 1 | 2013 | 15 | 0.460 |
Why?
|
| STAT3 Transcription Factor | 5 | 2023 | 90 | 0.450 |
Why?
|
| Carbon | 1 | 2014 | 105 | 0.440 |
Why?
|
| Oxides | 1 | 2013 | 89 | 0.430 |
Why?
|
| Azirines | 1 | 2010 | 2 | 0.370 |
Why?
|
| Aza Compounds | 1 | 2010 | 10 | 0.360 |
Why?
|
| Organic Chemicals | 1 | 2010 | 35 | 0.360 |
Why?
|
| Silicon Dioxide | 2 | 2005 | 34 | 0.320 |
Why?
|
| Molecular Conformation | 6 | 2017 | 152 | 0.320 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2010 | 11 | 0.310 |
Why?
|
| Adamantane | 3 | 2015 | 8 | 0.300 |
Why?
|
| Allyl Compounds | 2 | 2003 | 47 | 0.270 |
Why?
|
| Receptors, Drug | 2 | 2003 | 58 | 0.270 |
Why?
|
| Receptors, Cannabinoid | 4 | 2015 | 26 | 0.270 |
Why?
|
| Ligands | 5 | 2017 | 349 | 0.260 |
Why?
|
| Molecular Probes | 3 | 2015 | 23 | 0.250 |
Why?
|
| Structure-Activity Relationship | 7 | 2021 | 409 | 0.240 |
Why?
|
| Salicylic Acid | 1 | 2023 | 7 | 0.240 |
Why?
|
| Vinyl Compounds | 1 | 2003 | 5 | 0.230 |
Why?
|
| Camphor | 1 | 2002 | 1 | 0.220 |
Why?
|
| Fluorides | 1 | 2022 | 19 | 0.220 |
Why?
|
| Furans | 1 | 2003 | 38 | 0.220 |
Why?
|
| Peptides, Cyclic | 1 | 2002 | 29 | 0.210 |
Why?
|
| Diterpenes | 1 | 2002 | 92 | 0.200 |
Why?
|
| Esters | 2 | 2012 | 28 | 0.200 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 69 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 352 | 0.170 |
Why?
|
| Models, Molecular | 4 | 2014 | 808 | 0.170 |
Why?
|
| Amides | 3 | 2020 | 68 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2021 | 513 | 0.160 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1502 | 0.160 |
Why?
|
| Cannabinol | 1 | 2017 | 2 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 312 | 0.150 |
Why?
|
| Spectrophotometry, Infrared | 2 | 2007 | 37 | 0.150 |
Why?
|
| Deoxyglucose | 2 | 2007 | 19 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2007 | 289 | 0.130 |
Why?
|
| Thiourea | 1 | 2015 | 5 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2022 | 938 | 0.130 |
Why?
|
| Benzoates | 1 | 2015 | 16 | 0.130 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 32 | 0.130 |
Why?
|
| Glioma | 1 | 2015 | 79 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 803 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 111 | 0.120 |
Why?
|
| Alcohols | 1 | 2013 | 12 | 0.120 |
Why?
|
| Alkynes | 1 | 2013 | 50 | 0.120 |
Why?
|
| Isomerism | 2 | 2003 | 63 | 0.110 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 2231 | 0.110 |
Why?
|
| Benzopyrans | 1 | 2012 | 14 | 0.110 |
Why?
|
| Thiophenes | 1 | 2012 | 31 | 0.100 |
Why?
|
| Mice | 6 | 2022 | 5913 | 0.100 |
Why?
|
| Animals | 8 | 2022 | 15081 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 364 | 0.100 |
Why?
|
| Lithium Compounds | 1 | 2009 | 3 | 0.090 |
Why?
|
| Gases | 1 | 2009 | 24 | 0.090 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 265 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2022 | 928 | 0.080 |
Why?
|
| Humans | 11 | 2022 | 37093 | 0.080 |
Why?
|
| Protons | 1 | 2008 | 84 | 0.080 |
Why?
|
| Cyclohexylamines | 1 | 2007 | 12 | 0.070 |
Why?
|
| Crystallization | 1 | 2007 | 86 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 132 | 0.070 |
Why?
|
| Protein Binding | 3 | 2020 | 972 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1039 | 0.070 |
Why?
|
| Morpholines | 1 | 2006 | 69 | 0.070 |
Why?
|
| Alkylation | 1 | 2005 | 11 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2007 | 207 | 0.070 |
Why?
|
| Gels | 1 | 2005 | 42 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 260 | 0.070 |
Why?
|
| Rats | 4 | 2017 | 3483 | 0.060 |
Why?
|
| Apoptosis | 2 | 2022 | 1398 | 0.060 |
Why?
|
| Cations | 1 | 2003 | 45 | 0.060 |
Why?
|
| Phenylcarbamates | 1 | 2002 | 2 | 0.060 |
Why?
|
| Isotope Labeling | 1 | 2003 | 26 | 0.060 |
Why?
|
| Amylose | 1 | 2002 | 5 | 0.060 |
Why?
|
| Radioligand Assay | 2 | 2015 | 66 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 2003 | 35 | 0.060 |
Why?
|
| Carbamates | 1 | 2002 | 12 | 0.060 |
Why?
|
| NADP | 1 | 2022 | 38 | 0.050 |
Why?
|
| Bromine | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1198 | 0.050 |
Why?
|
| Trees | 1 | 2002 | 19 | 0.050 |
Why?
|
| Mandelic Acids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Depsipeptides | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cyanobacteria | 1 | 2002 | 23 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2021 | 21 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2021 | 12 | 0.050 |
Why?
|
| beta Catenin | 1 | 2021 | 48 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2020 | 83 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 421 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 112 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 275 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2021 | 325 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 251 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2022 | 1908 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 997 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 739 | 0.040 |
Why?
|
| DNA | 1 | 2020 | 574 | 0.040 |
Why?
|
| Cell Survival | 1 | 2020 | 864 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 571 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 677 | 0.040 |
Why?
|
| Female | 3 | 2022 | 20969 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 807 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 61 | 0.030 |
Why?
|
| Molecular Probe Techniques | 1 | 2015 | 7 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2015 | 132 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 337 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 523 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 381 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 117 | 0.030 |
Why?
|
| Binding Sites | 1 | 2012 | 651 | 0.020 |
Why?
|
| Solutions | 1 | 2009 | 62 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 112 | 0.020 |
Why?
|
| Quantum Theory | 1 | 2009 | 78 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 73 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2009 | 216 | 0.020 |
Why?
|
| Polymers | 1 | 2009 | 121 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 10129 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1354 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2002 | 21 | 0.010 |
Why?
|
| Membranes | 1 | 2002 | 19 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2002 | 25 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 1346 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 199 | 0.010 |
Why?
|
| Kidney | 1 | 2002 | 337 | 0.010 |
Why?
|
| Male | 1 | 2015 | 20025 | 0.010 |
Why?
|